Click amount to donate direct to CounterPunch
  • $25
  • $50
  • $100
  • $500
  • $other
  • use PayPal
Keep CounterPunch ad free. Support our annual fund drive today!

The Big Profits in Biowarfare Research


A number of major pharmaceutical corporations and biotech firms are concealing the nature of the biological warfare research work they are doing for the U.S. government.

Since their funding comes from the National Institutes of Health, the recipients are obligated under NIH guidelines to make their activities public. Not disclosing their ops raises the suspicion they may be engaged in forbidden kinds of germ warfare research.

According to the Sunshine Project, a nonprofit arms control watchdog operating out of Austin, Texas, among corporations holding back information about their activities are:

Abbott Laboratories, BASF Plant Science, Bristol-Myers Squibb, DuPont Central Research and Development, Eli Lilly Corp., Embrex, GlaxoSmithKline, Hoffman-LaRoche, Merck & Co., Monsanto, Pfizer Inc., Schering-Plough Research Institute, and Syngenta Corp. of Switzerland.

In case you didn’t know it, the White House since 9/11 has called for spending $44-billion on biological warfare research, a sum unprecedented in world history, and an obliging Congress has authorized it.

Thus, some of the deadliest pathogens known to humankind are being rekindled in hundreds of labs in pharmaceutical houses, university biology departments, and on military bases.

An international convention the U.S. signed forbids it to stockpile, manufacture or use biological weapons. But if the U.S. won’t say what’s going down in those laboratories other countries are going to assume the worst and a biowarfare arms race will be on, if it isn’t already.

Sunshine says failure to disclose operations also puts corporate employees involved in this work at risk. Only 8,500, or 16%, of the 52,000 workers employed at the top 20 U.S. biotech firms work at an NIH guidelines-compliant company, Sunshine says.

Francis Boyle, an international law authority at the University of Illinois, Champaign, says pursuant to national strategy directives adopted by Bush in 2002, the Pentagon “is now gearing up to fight and win’ biological warfare without prior public knowledge and review.” Boyle said the Pentagon’s Chemical and Biological Defense Program was revised in 2003 to endorse “first-use” strike in war. Boyle said the program includes Red Teaming, which he described as “plotting, planning, and scheming how to use biowarfare.”

Besides the big pharmaceutical houses, the biowarfare buildup is getting an enthusiastic response from academia, which sees new funds flowing from Washington’s horn of plenty. “American universities have a long history of willingly permitting their research agenda, researchers, institutes and laboratories to be co-opted, corrupted, and perverted by the Pentagon and the CIA,” Boyle says.

What’s more, the Bush administration is pouring billions in biowarfare research while some very real killers, such as influenza, are not being cured.

In 2006, the NIH got $120 million to combat influenza, which kills about 36,000 Americans annually but it got $1.76 billion for biodefense, much of it spent to research anthrax. How many people has anthrax killed lately? Well, let’s see, there were those five people killed in the mysterious attacks on Congress of October, 2001 — attacks that suspiciously emanated from a government laboratory at Fort Detrick, Md.

One would think the FBI might apprehend the perpetrator whose attack shut down the Congress of the United States but nearly six years have gone by and it hasn’t caught anybody. Seem a bit odd to you? Some folks suspect the anthrax attack was an inside job to panic the country into a huge biowarfare buildup to “protect” America from “terrorists.”

Milton Leitenberg, of the University of Maryland’s School of Public Policy, though, says the risk of terrorists and nonstate actors using biological agents against the U.S. “has been systematically and deliberately exaggerated” by administration scare-mongering.

And molecular biologist Jonathan King of Massachusetts Institute of Technology says, “the Bush administration launched a major program which threatens to put the health of our people at far greater risk than the hazard to which they claimed to have been responding.” King added President Bush’s policies “do not increase the security of the American people” but “bring new risk to our population of the most appalling kind.”

In the absence of any credible foreign threat, Sunshine’s Hammond said, “Our biowarfare research is defending ourselves from ourselves. It’s a dog chasing its tail.” Sadly, it looks more and more every day like a mad dog.

SHERWOOD ROSS has worked as a reporter for major dailies and wire services. Reach him at



More articles by:

2016 Fund Drive
Smart. Fierce. Uncompromised. Support CounterPunch Now!

  • cp-store
  • donate paypal

CounterPunch Magazine


Weekend Edition
October 28, 2016
Friday - Sunday
John Pilger
Inside the Invisible Government; War, Propaganda, Clinton & Trump
Andrew Levine
The Hillary Era is Coming: Worry!
Gary Leupp
Seven World-Historical Achievements of the Iraq Invasion of 2003
Paul Street
Standing Rock Water-Protectors Waterboarded While the Cleveland Indians Romped
Stanley L. Cohen
Israel: 1984 Everlasting
Michael Brenner
American Foreign Policy in the Post-Trump Era
Luciana Bohne
Crossing the Acheron: Back to Vietnam
Robert Hunziker
The Political Era of Climate Refugees
Stephen Cooper
Alabama’s Last Execution was an Atrocity
Pete Dolack
Work Harder So Speculators Can Get More
Joyce Nelson
Canadians Launch Constitutional Challenge Against CETA
John Laforge
US Uranium Weapons Have Been Used in Syria
Paul Edwards
The Vision Thing ’16
Arshad Khan
Hillary, Trump and Sartre: How Existentialism Disrobes the Major Presidential Candidates
Peter Lee
It’s ON! Between Duterte and America
Joseph Grosso
Starchitects in the City: Vanity Fair and Gentrification
Patrick Carr
Economic Racial Disparity in North Carolina
David Swanson
Public vs. Media on War
Chris Gilbert
Demo Derby in Venezuela: The Left’s New Freewheeling Politics
Binoy Kampmark
Nobel Confusion: Ramos-Horta, Trump and World Disorder
Stephen Cooper
Alabama’s Last Execution Was an Atrocity
Binoy Kampmark
Nobel Confusion: Ramos-Horta, Trump and World Disorder
Russell Mokhiber
Lucifer’s Banker: Bradley Birkenfeld on Corporate Crime in America
Ron Jacobs
Death to the Fascist Insect! The SLA and the Cops
Cesar Chelala
Embargo on Cuba is an Embarrassment for the United States
Jack Smith
And the Winner Is….
Ken Knabb
Beyond Voting: the Limits of Electoral Politics
Matt Peppe
An Alternate Narrative on Hillary Clinton and Donald Trump
James Rothenberg
Water Under the Bridge
Louis Yako
Remembering Rasul Gamzatov: The Poet of the People
Brian Cloughley
The US, NATO and the Pope
Louis Proyect
The Outsider-Insider: Isaac Babel’s Big Mistake
Martin Billheimer
Now and Then, Ancient Sorceries
October 27, 2016
Paul Street
An Identity-Politicized Election and World Series Lakefront Liberals Can Love
Matthew Stevenson
Sex and the Presidential City
Jim Kavanagh
Tom Hayden’s Haunting
CJ Hopkins
The Pathologization of Dissent
Mike Merryman-Lotze
The Inherent Violence of Israel’s Gaza Blockade
Robert Fisk
Is Yemen Too Much for the World to Take?
Shamus Cooke
Stopping Hillary’s Coming War on Syria
Jan Oberg
Security Politics and the Closing of the Open Society
Ramzy Baroud
The War on UNESCO: Al-Aqsa Mosque is Palestinian and East Jerusalem is Illegally Occupied
Colin Todhunter
Lower Yields and Agropoisons: What is the Point of GM Mustard in India?
Norman Pollack
The Election: Does It Matter Who Wins?
Nyla Ali Khan
The Political and Cultural Richness of Kashmiriyat